Circa Segreteria Mucomixx

Questo autore non ha riempito alcun dettaglio.
Finora Segreteria Mucomixx ha creato 31 post nel blog.

L. brevis DSM27961 come strategia preventiva per la malattia di Alzheimer

2022-12-16T16:43:32+00:00

La malattia di Alzheimer è un disordine neurovegetativo che vede tra le principali cause eziologiche una predisposizione genetica e processi infettivi; fra questi ultimi, è sempre stato molto controverso l’innesco per questa patologia rappresentato delle

L. brevis DSM27961 come strategia preventiva per la malattia di Alzheimer2022-12-16T16:43:32+00:00

Multi-Sensor Approach for the Monitoring of Halitosis Treatment via Lactobacillus brevis (CD2)—Containing Lozenges—A Randomized, Double-Blind Placebo-Controlled Clinical Trial

2020-06-08T13:29:45+00:00

Marchetti, E., Tecco, S., Santonico, M., Vernile, C., Ciciarelli, D., Tarantino, E., et al. Abstract The aim of this randomized clinical trial was to evaluate whether a recently described multi-sensor approach called BIONOTE® is accurate

Multi-Sensor Approach for the Monitoring of Halitosis Treatment via Lactobacillus brevis (CD2)—Containing Lozenges—A Randomized, Double-Blind Placebo-Controlled Clinical Trial2020-06-08T13:29:45+00:00

Modulation of the host response by probiotic L actobacillus brevis CD 2 in experimental gingivitis

2020-06-08T13:31:39+00:00

Lee, J.-K., Kim, S.-J., Ko, S.-H., Ouwehand, A. C., & Ma, D. S. Abstract Objective - Probiotic L actobacillus brevis CD 2 (CD 2) exerts anti‐inflammatory properties by preventing nitric oxide synthesis. It is hypothesized that oral

Modulation of the host response by probiotic L actobacillus brevis CD 2 in experimental gingivitis2020-06-08T13:31:39+00:00

Effects of vaginal lactobacilli in Chlamydia trachomatis infection

2020-06-08T13:32:09+00:00

Mastromarino, P., Di Pietro, M., Schiavoni, G., Nardis, C., Gentile, M., & Sessa, R. (2014). Abstract Increasing evidence indicates that abnormal vaginal flora lacking lactobacilli facilitates the acquisition of several sexually transmitted diseases including Chlamydia trachomatis. C. trachomatis, the most common bacterial agent

Effects of vaginal lactobacilli in Chlamydia trachomatis infection2020-06-08T13:32:09+00:00

Topical treatment with probiotic Lactobacillus brevis CD 2 inhibits experimental periodontal inflammation and bone loss

2020-06-08T13:32:32+00:00

Maekawa, T., & Hajishengallis, G. Abstract Background and Objective - An increasing body of evidence suggests that the use of probiotic bacteria is a promising intervention approach for the treatment of inflammatory diseases with a

Topical treatment with probiotic Lactobacillus brevis CD 2 inhibits experimental periodontal inflammation and bone loss2020-06-08T13:32:32+00:00

A comparative study of the effect of probiotics on cariogenic biofilm model for preventing dental caries

2020-06-08T13:32:56+00:00

Lee, S.-H., & Kim, Y.-J. (2014) Abstract Dental caries is induced by oral biofilm containing Streptococcus mutans. Probiotic bacteria were mainly studied for effect on the gastrointestinal tract and have been known to promote human health.

A comparative study of the effect of probiotics on cariogenic biofilm model for preventing dental caries2020-06-08T13:32:56+00:00

Lactobacillus brevisCD2 inhibits Prevotella melaninogenica biofilm

2020-06-08T13:23:19+00:00

Vuotto, C., Barbanti, F., Mastrantonio, P., & Donelli, G. (2013) Abstract Objectives: To evaluate the ability of the probiotic strain L actobacillus brevis CD 2 to inhibit the opportunistic anaerobe P revotella melaninogenica (PM 1), a well‐known causative agent of

Lactobacillus brevisCD2 inhibits Prevotella melaninogenica biofilm2020-06-08T13:23:19+00:00

Evaluation of the effect of probiotic (Inersan®) alone, combination of probiotic with doxycycline and doxycycline alone on aggressive periodontitis – a clinical and microbiological study

2020-06-08T13:33:31+00:00

Shah, M. P., Gujjari, S. K., & Chandrasekhar, V. S. (2013) Abstract Introduction: The purpose of the present study was to evaluate the effect of a probiotic (Inersan®) alone, a combination of the probiotic with doxycycline

Evaluation of the effect of probiotic (Inersan®) alone, combination of probiotic with doxycycline and doxycycline alone on aggressive periodontitis – a clinical and microbiological study2020-06-08T13:33:31+00:00

Effect of a daily dose of Lactobacillus brevis CD2 lozenges in high caries risk schoolchildren

2020-06-08T13:33:55+00:00

Guglielmo Campus & Fabio Cocco & Giovanna Carta & Maria Grazia Cagetti & Charlotte Simark-Mattson & Laura Strohmenger & Peter Lingströ Abstract Objectives - A double-blind, randomised, placebo-controlled clinical trial was performed to validate the

Effect of a daily dose of Lactobacillus brevis CD2 lozenges in high caries risk schoolchildren2020-06-08T13:33:55+00:00

Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: A randomized double-blind placebo-controlled study

2020-06-08T13:34:26+00:00

Sharma, A., Rath, G. K., Chaudhary, S. P., Thakar, A., Mohanti, B. K., & Bahadur, S. (2012) Abstract Background Oral mucositis is a frequent and serious complication in patients receiving chemo-radiotherapy for head and neck

Lactobacillus brevis CD2 lozenges reduce radiation- and chemotherapy-induced mucositis in patients with head and neck cancer: A randomized double-blind placebo-controlled study2020-06-08T13:34:26+00:00
© Copyright 2020- Mendes Srl - P.IVA 02102651003 - Via Nuoro, 12 - 00040 Ardea (RM)
Privacy Policy | Cookie Policy